Hemispherx Biopharma

Stock Update (NYSE MKT:HEB): Hemispherx BioPharma, Inc Europe N.V./S.A. Submits Application for Orphan Medicine Designation to the EMA for Alferon N Injection(R)

Hemispherx BioPharma, Inc (NYSEMKT:HEB) announces that they have submitted an application for orphan drug designation to the European Medicines Agency (EMA) for Alferon N …

Corey Williams — July 15, 2015, 8:46 AM EDT

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts